Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Roberto Berni Canani, assistant professor of paediatrics1, Pia Cirillo, paediatrician1, Gianluca Terrin, paediatrician1, Luisa Cesarano, paediatrician1, Maria Immacolata Spagnuolo, paediatrician1, Anna De Vincenzo, paediatrician1, Fabio Albano, paediatrician1, Annalisa Passariello, paediatrician1, Giulio De Marco, paediatrician1, Francesco Manguso, consultant physician in gastroenterology2, Alfredo Guarino, professor of paediatrics1
1 Department of Paediatrics, University of Naples Federico II, Naples, Italy, 2 Department of Clinical and Experimental Medicine, University of Naples Federico II
Correspondence to: A Guarino alfguari{at}unina.it
Design Randomised controlled clinical trial in collaboration with family paediatricians over 12 months.
Setting Primary care.
Participants Children aged 3-36 months visiting a family paediatrician for acute diarrhoea.
Intervention Children's parents were randomly assigned to receive written instructions to purchase a specific probiotic product: oral rehydration solution (control group); Lactobacillus rhamnosus strain GG; Saccharomyces boulardii; Bacillus clausii; mix of L delbrueckii var bulgaricus, Streptococcus thermophilus, L acidophilus, and Bifidobacterium bifidum; or Enterococcus faecium SF68.
Main outcome measures Primary outcomes were duration of diarrhoea and daily number and consistency of stools. Secondary outcomes were duration of vomiting and fever and rate of admission to hospital. Safety and tolerance were also recorded.
Results 571 children were allocated to intervention. Median duration of diarrhoea was significantly shorter (P<0.001) in children who received L rhamnosus strain GG (78.5 hours) and the mix of four bacterial strains (70.0 hours) than in children who received oral rehydration solution alone (115.0 hours). One day after the first probiotic administration, the daily number of stools was significantly lower (P<0.001) in children who received L rhamnosus strain GG and in those who received the probiotic mix than in the other groups. The remaining preparations did not affect primary outcomes. Secondary outcomes were similar in all groups.
Conclusions Not all commercially available probiotic preparations are effective in children with acute diarrhoea. Paediatricians should choose bacterial preparations based on effectiveness data.
Trial registration number Current Controlled Trials ISRCTN56067537 [controlled-trials.com] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses